对“HOPE4MCI研究：AGB101治疗减缓阿尔茨海默病所致轻度认知障碍的APOE ε4非携带者内嗅皮质萎缩进展”的勘误
Correction to "The HOPE4MCI study: AGB101 treatment slows progression of entorhinal cortex atrophy in APOE ε4 non-carriers with mild cognitive impairment due to Alzheimer's disease".
出版信息
Alzheimers Dement (N Y). 2025 Jul 10;11(3):e70131. doi: 10.1002/trc2.70131. eCollection 2025 Jul-Sep.
Abstract
[This corrects the article DOI: 10.1002/trc2.70004.].
摘要
[本文更正了文章的数字对象标识符：10.1002/trc2.70004。]
相似文献
1
Correction to "The HOPE4MCI study: AGB101 treatment slows progression of entorhinal cortex atrophy in APOE ε4 non-carriers with mild cognitive impairment due to Alzheimer's disease".对“HOPE4MCI研究：AGB101治疗减缓阿尔茨海默病所致轻度认知障碍的APOE ε4非携带者内嗅皮质萎缩进展”的勘误
Alzheimers Dement (N Y). 2025 Jul 10;11(3):e70131. doi: 10.1002/trc2.70131. eCollection 2025 Jul-Sep.
2
The HOPE4MCI study: AGB101 treatment slows progression of entorhinal cortex atrophy in ε4 non-carriers with mild cognitive impairment due to Alzheimer's disease.HOPE4MCI研究：AGB101治疗可减缓因阿尔茨海默病导致轻度认知障碍的ε4非携带者内嗅皮质萎缩的进展。
Alzheimers Dement (N Y). 2024 Oct 11;10(4):e70004. doi: 10.1002/trc2.70004. eCollection 2024 Oct-Dec.
3
Neuropsychiatric symptoms and apolipoprotein E genotypes in neurocognitive disorders.神经认知障碍中的神经精神症状与载脂蛋白E基因型
Neural Regen Res. 2025 Mar 25. doi: 10.4103/NRR.NRR-D-24-01274.
4
Galantamine for dementia due to Alzheimer's disease and mild cognitive impairment.加兰他敏治疗阿尔茨海默病所致痴呆和轻度认知障碍。
Cochrane Database Syst Rev. 2024 Nov 5;11(11):CD001747. doi: 10.1002/14651858.CD001747.pub4.
5
Influence of APOE ε4 on performance of CSF biomarkers in differentiating clinical Alzheimer's disease.APOE ε4对脑脊液生物标志物鉴别临床阿尔茨海默病效能的影响。
J Prev Alzheimers Dis. 2025 Apr;12(4):100065. doi: 10.1016/j.tjpad.2025.100065. Epub 2025 Jan 17.
6
The HOPE4MCI study: A randomized double-blind assessment of AGB101 for the treatment of MCI due to AD.HOPE4MCI研究：AGB101治疗阿尔茨海默病所致轻度认知障碍的随机双盲评估。
Alzheimers Dement (N Y). 2024 Jan 24;10(1):e12446. doi: 10.1002/trc2.12446. eCollection 2024 Jan-Mar.
7
Donepezil for dementia due to Alzheimer's disease.多奈哌齐用于治疗阿尔茨海默病所致的痴呆。
Cochrane Database Syst Rev. 2018 Jun 18;6(6):CD001190. doi: 10.1002/14651858.CD001190.pub3.
8
CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis.脑脊液和血液生物标志物在阿尔茨海默病诊断中的应用：系统评价和荟萃分析。
Lancet Neurol. 2016 Jun;15(7):673-684. doi: 10.1016/S1474-4422(16)00070-3. Epub 2016 Apr 8.
9
18F PET with flutemetamol for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).使用氟代甲磺酸去甲肾上腺素的18F正电子发射断层显像用于轻度认知障碍（MCI）患者中阿尔茨海默病性痴呆及其他痴呆的早期诊断。
Cochrane Database Syst Rev. 2017 Nov 22;11(11):CD012884. doi: 10.1002/14651858.CD012884.
10
Baseline habitual dietary nitrate intake and Alzheimer's Disease related neuroimaging biomarkers in the Australian Imaging, Biomarkers and Lifestyle study of ageing.在澳大利亚衰老成像、生物标志物和生活方式研究中，基线习惯性膳食硝酸盐摄入量与阿尔茨海默病相关神经影像学生物标志物。
J Prev Alzheimers Dis. 2025 Jun;12(6):100161. doi: 10.1016/j.tjpad.2025.100161. Epub 2025 Apr 11.
Zotero 插件